A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/10/2009	US20090306120 Terpolymers containing lactide and glycolide
12/10/2009	US20090306119 Non-Codeine Opioid Analgesic Process And Formulations
12/10/2009	US20090306118 Trisubstituted Thiophenes as Progesterone Receptor Modulators
12/10/2009	US20090306117 Rosuvastatin zinc salt
12/10/2009	US20090306116 Pyrimidine derivatives for the inhibition of igf-ir tyrosine kinase activity
12/10/2009	US20090306115 Phenyl ethyne compounds
12/10/2009	US20090306114 Polymorphic and Other Crystalline Forms of Cis-FTC
12/10/2009	US20090306113 Pharmaceutical formulation
12/10/2009	US20090306112 Antiviral protease inhibitors
12/10/2009	US20090306111 Pharmaceutical Comprising PPAR Agonist
12/10/2009	US20090306110 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/10/2009	US20090306109 Fungicide active substance combinations
12/10/2009	US20090306108 Substituted pyrimidinones
12/10/2009	US20090306107 Organic Compounds
12/10/2009	US20090306106 Forms of crystalline lapatinib and processes for preparation thereof
12/10/2009	US20090306105 Bicyclic heterocycles, medicaments containing these compounds, their use and process for preparing them
12/10/2009	US20090306104 Use of Lck inhibitors for treatment of immunologic diseases
12/10/2009	US20090306103 Pyridonecarboxamide derivatives useful in treating hyper-proliferative and angiogenesis disorders
12/10/2009	US20090306102 2-pyridin-2-yl-quinazoline derivatives as potassium channel modulating agents for the treatment of respiratory diseases
12/10/2009	US20090306101 Combination treatment of cancer comprising egfr/her2 inhibitors
12/10/2009	US20090306100 Methods of treating schizophrenia
12/10/2009	US20090306099 Monitoring human response to antiviral agents; obtain tissue sample, extract nucleotide sequences, detect tumor necrosis factor genotype, presence of genotype indicates sensitivity to viricide; treating a male Caucasian human in need of treatment with abacavir
12/10/2009	US20090306098 Combination of roscovitine and a hdca inhibitor to treat proliferative diseases
12/10/2009	US20090306097 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
12/10/2009	US20090306096 Novel Isoxazoles and Methods of Use Thereof
12/10/2009	US20090306095 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
12/10/2009	US20090306094 Pharmacogenetics around BCR-ABL individuals with drug bosutinib; determining if they will have drug resistance
12/10/2009	US20090306093 Method for treating patient having benign prostate hyperplasia
12/10/2009	US20090306092 Method for treating cognitive deficits
12/10/2009	US20090306091 Antimalarial therapy using a combination of synthetic artemisinin derivative and bisquinoline derivative
12/10/2009	US20090306090 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
12/10/2009	US20090306089 Compounds
12/10/2009	US20090306088 Substituted heteroaryl pyridopyrimidone derivatives
12/10/2009	US20090306087 Compounds and Methods for Kinase Modulation, and Indications Therefor
12/10/2009	US20090306086 Compounds and methods for kinase modulation, and indications therefor
12/10/2009	US20090306085 Hcv protease inhibitors and uses thereof
12/10/2009	US20090306084 Heteroaryl 11-beta hydroxysteroid dehydrogenase type i inhibitors
12/10/2009	US20090306083 Use of Trifluoromethyl Substituted Benzamides in teh Treatment of Neurological Disorders
12/10/2009	US20090306082 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
12/10/2009	US20090306081 Solid Dosage Formulations of Hydralazine Compounds and Nitric Oxide Donor Compounds
12/10/2009	US20090306080 Veterinary formulation
12/10/2009	US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
12/10/2009	US20090306078 Compounds that inhibit hif-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component
12/10/2009	US20090306077 Novel n- (2-aminophenyl) benzamide derivative having urea structure
12/10/2009	US20090306076 Morpholine Carboxamide Prokineticin Receptor Antagonists
12/10/2009	US20090306075 Chemical compounds
12/10/2009	US20090306074 Thiazolidinedione derivatives as p13 kinase inhibitors
12/10/2009	US20090306073 Thiazole and Thiophene Analogues, and Their Use in Treating Autoimmune Diseases and Cancers
12/10/2009	US20090306072 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
12/10/2009	US20090306071 such as 2-cyclopentyl-9-(1-methyl-1H-pyrazol-4-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one, used for treatment of myeloproliferative disorders or cancer
12/10/2009	US20090306070 Tetra-o-substituted butane-bridge modified ndga derivatives, their synthesis and pharmaceutical use
12/10/2009	US20090306069 Azolidinone-vinyl fused-benzene derivatives
12/10/2009	US20090306068 Novel enantiomeric pure beta agonists, manufacturing and use as a medicaments thereof
12/10/2009	US20090306067 2, 4-diaminopyrimidide derivates and their use for the treatment of cancer
12/10/2009	US20090306066 Peptide deformylase inhibitors
12/10/2009	US20090306065 Aerosol formulation for inhalation containing an anticholinergic agent
12/10/2009	US20090306064 5-[4-(3-Methoxypropyl)3.4-dihydro-2H-benzo[1,4]oxazin-6-ylmethoxy]-4 -(4-phenoxyphenyl)-piperidin-3-ol, used for treating high blood pressure, glaucoma, myocardial infarction, restenoses or stroke
12/10/2009	US20090306063 Oxadiazoanthracene Compounds For The Treatment Of Diabetes
12/10/2009	US20090306062 2,5-Disubstituted Piperidines
12/10/2009	US20090306059 Cyclic amine derivative having substituted alkyl group
12/10/2009	US20090306058 Sulphone Derivatives for Treatment of Cancer
12/10/2009	US20090306057 [1,2,4]thiadiazine 1,1-dioxide compounds
12/10/2009	US20090306056 Pyrrolo-pyridine kinase modulators
12/10/2009	US20090306055 Phenylazole compounds, production process and antioxidants
12/10/2009	US20090306054 Integrase inhibitors
12/10/2009	US20090306053 Highly selective rho-kinase inhibitor
12/10/2009	US20090306052 Indenyl derivatives and use thereof for the treatment of neurological disorders
12/10/2009	US20090306051 Methods and compositions for the treatment of epilepsy, seizure disorders, and other CNS disorders
12/10/2009	US20090306050 Treatment and prevention of depression with pain, depression secondary to pain, and of neuropathic pain
12/10/2009	US20090306049 Treatment of Barrett's Esophagus
12/10/2009	US20090306048 Pharmaceutical use of substituted piperidine carboxamides
12/10/2009	US20090306047 Heterocyclic aspartyl protease inhibitors
12/10/2009	US20090306046 Method of treatment of hormone depletion induced vasomotor symptoms
12/10/2009	US20090306045 Inhibition of Glycogen Synthase Kinase and Methods of Treating Autoimmune or Immune Inflammatory Disease
12/10/2009	US20090306044 Quinazoline derivatives for the treatment of cancer diseases
12/10/2009	US20090306043 Pyrrolidine ether derivatives as nk3 receptor antagonists
12/10/2009	US20090306042 Novel Compounds 010
12/10/2009	US20090306041 Inhibitors of Bruton's tyrosine kinase
12/10/2009	US20090306040 Mono and Combination Therapy of M1/M4 Agonist (Sabcomeline) for Treatment of Negative Symptoms of Schizophrenia
12/10/2009	US20090306039 Compounds and compositions as itpkb inhibitors
12/10/2009	US20090306038 2-Aminopyrimidine derivatives as modulators of the histamine H4 receptor activity
12/10/2009	US20090306037 Combination of a Dipeptidyl Peptidase-IV Inhibitor and a Cannabinoid CB1 Receptor Antagonist for the Treatment of Diabetes and Obesity
12/10/2009	US20090306036 Methods of screening agents, conjugates or conjugate moieties for transport by a pept2 transporter
12/10/2009	US20090306035 Compounds and Methods for modulating the Silencing of a Polynucleotide of Interest
12/10/2009	US20090306034 Use of picoplatin to treat colorectal cancer
12/10/2009	US20090306033 Novel cyclic peptides
12/10/2009	US20090306032 Use of solid lipid nanoparticles Comprising Cholesteryl Propionate and/or Cholesteryl Butyrate
12/10/2009	US20090306031 5alpha-ANDROSTANE-3,6,17-TRIONE (KNELLER'S TRIONE) AND METHODS OF USE THEREFOR
12/10/2009	US20090306030 Methods Of Inhibiting Osteoclast Activity
12/10/2009	US20090306029 Process for the preparation of sterile powdered pharmaceutical compounds
12/10/2009	US20090306028 Compositions and methods for treating inflammatory disorders
12/10/2009	US20090306027 Genetic risk assessment in heart failure: impact of the genetic variation of g-protein beta 3 subunit polymorphism
12/10/2009	US20090306026 Pharmaceutical Formulations and Uses Thereof in the Treatment of Female Sexual Dysfunction
12/10/2009	US20090306025 Method and composition for skin inflammation and discoloration
12/10/2009	US20090306024 Combination preparations of o-acetylsalicylic acid salts
12/10/2009	US20090306023 Stable organic peroxide compositions
12/10/2009	US20090306022 7-substituted tetracycline compounds
12/10/2009	US20090306021 Antimicrobial therapy for bacterial infections
12/10/2009	US20090306020 Combination therapy comprising diaryl ureas for treating diseases
12/10/2009	US20090306019 Compositions for treatment of eosinophilia and related disorders

1 ... 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 ... 7860